Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathological Factors Influencing Survival After Trimodality Treatment in Non-Metastatic Esophageal Cancer: A Retrospective Single-Center Study.

Journal of clinical medicine·2026
Same author

Determinants of Pain Care Quality After Abdominal Surgery: Fear and Postoperative Pain.

Pain management nursing : official journal of the American Society of Pain Management Nurses·2026
Same author

The impact of timing of esophagectomy after neoadjuvant chemoradiotherapy on pathological outcomes and survival in patients with pure esophageal squamous cell carcinoma.

Current problems in surgery·2026
Same author

Prediction of transient hypocalcemia following total thyroidectomy using machine learning methods.

Current problems in surgery·2026
Same author

Comparison of open and laparoscopic surgical techniques in colorectal cancer surgery: Early and late results.

Medicine·2026
Same author

Impact of Minimally Invasive Surgery on Systemic Immune Inflammation Index in Colorectal Cancer Patients.

Journal of laparoendoscopic & advanced surgical techniques. Part A·2026

Related Experiment Video

Updated: May 22, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

199

The Association of the Cancer Inflammation Prognostic Index with Microsatellite Instability, Tumor Budding and

Uğur Topal1, Sercan Yüksel2, Mehmet Zişan Songür2

  • 1Department of Surgical Oncology, Başakşehir Çam and Sakura City Hospital, 34480 İstanbul, Turkey.

Annali Italiani Di Chirurgia
|March 16, 2025
PubMed
Summary
This summary is machine-generated.

A high Cancer Inflammation Prognostic Index (CIPI) score indicates poorer prognosis in colorectal cancer patients. This inflammation marker is linked to aggressive tumor features and reduced survival rates, suggesting closer monitoring for affected individuals.

More Related Videos

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.0K

Related Experiment Videos

Last Updated: May 22, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

199
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.0K

Area of Science:

  • Oncology
  • Inflammation Biomarkers
  • Colorectal Cancer Research

Background:

  • The Cancer Inflammation Prognostic Index (CIPI) is an emerging biomarker.
  • Its association with tumor characteristics and patient outcomes in colorectal cancer requires further elucidation.

Purpose of the Study:

  • To investigate the relationship between the Cancer Inflammation Prognostic Index (CIPI) and microsatellite instability (MSI), tumor budding, and prognosis in colorectal cancer (CRC).

Main Methods:

  • Serum CIPI was calculated for 189 patients with stage 1-3 colorectal cancer.
  • Patients were stratified into low (Group 1, n=94) and high (Group 2, n=95) CIPI score groups based on ROC analysis.
  • Clinical and histopathological data, including MSI, tumor budding, and survival, were analyzed.

Main Results:

  • A high CIPI score (>8.54) was a significant predictor of mortality (AUC: 0.712).
  • High CIPI group showed higher C-reactive protein, neutrophil counts, CEA, Ca 19.9, and tumor diameter, with lower albumin levels.
  • High CIPI was independently associated with significantly poorer disease-free survival (HR=3.280) and overall survival (HR=3.383).

Conclusions:

  • Elevated CIPI scores correlate with adverse histopathological features and diminished survival in colorectal cancer.
  • Patients with high CIPI may benefit from intensified monitoring or more aggressive therapeutic strategies to improve outcomes.